Quintessence Biosciences forms cancer therapeutic advisory board

MADISON – Quintessence Biosciences, Inc. has formed a scientific advisory board to guide the company in its development of cancer therapeutics.

Announced last week by President and Chief Executive Officer Ralph Kauten, the board will consist of distinguished scientific leaders who will help supplement the scientific and medical knowledge within Quintessence Biosciences, Inc. They will also assist the company as it designs, conducts and evaluates its drug development plan, including the results of its preclinical and clinical studies.

“Cancer affects one of every three people at some point during their life,” Kauten said. “Quintessence Biosciences must have access to the best medical and scientific guidance in order to successfully turn innovative science into effective medicines. With these scientific advisors, I am confident that we can find the right way.”

The scientific advisors include:

· Howard H. Bailey, M.D., associate professor in the departments of medicine, obstetrics and gynecology of the University of Wisconsin Comprehensive Cancer Center
· Thomas J. Burke, Ph.D., faculty member at the University of Wisconsin-Madison and co-founder and former chief scientific officer of PanVera Corporation
· Anthony J. Clemento, Jr., former vice president for scientific and regulatory consulting for Covance Laboratories
· Laura L. Kiessling, Ph.D., professor of chemistry and biochemistry at UW-Madison and co-founder of Quintessence Biosciences, Inc.
· Ronald T. Raines, Ph.D., professor of biochemistry and chemistry at UW-Madison, co-founder of Quintessence Biosciences, Inc. and inventor of the EVade ribonuclease technology
· Paul M. Sondel, M.D., Ph.D., professor in the departments of pediatrics, human oncology and genetics at the University of Wisconsin Comprehensive Cancer Center

Founded in 2003, Quintessence Biosciences, Inc. is a company engaged in creating products based on chemistry and biochemistry technologies discovered at UW-Madison and licensed from the Wisconsin Alumni Research Foundation.